Alembic Pharmaceuticals Limited (BOM:533573)
764.05
+12.95 (1.72%)
At close: Apr 27, 2026
Alembic Pharmaceuticals Market Cap
Alembic Pharmaceuticals has a market cap or net worth of 149.27 billion as of April 28, 2026. Its market cap has decreased by -13.83% in one year.
Market Cap
149.27B
Enterprise Value
162.69B
Revenue
72.67B
Ranking
n/a
PE Ratio
23.73
Stock Price
764.05
Market Cap Chart
Since September 21, 2011, Alembic Pharmaceuticals's market cap has increased from 9.00B to 149.27B, an increase of 1,558.25%. That is a compound annual growth rate of 21.19%.
Market Cap History
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Jubilant Pharmova | 151.24B |
| Rubicon Research | 157.95B |
| Caplin Point Laboratories | 134.04B |
| Granules India | 172.24B |
| AstraZeneca Pharma India | 214.40B |
| CORONA Remedies | 103.13B |
| Viyash Scientific | 91.13B |
| Procter & Gamble Health | 85.93B |